We offer a wide range of dosage form manufacturing and development capabilities, providing high pharmaceutical quality that has been broadly certified.
We own the first U.S. FDA-approved manufacturing facility for injections in Asia (besides Japan).
One-Stop CDMO Services
From laboratory to market, we quickly turn your ideas into commercialized products
As a leading pharmaceutical company specializing in the development and manufacture of protein-based drug products and small molecule injectable drugs, we are your ideal one-stop-shop CDMO services provider. Our services include product formulation and manufacturing process development, analytical method development and validation, trial batch/registration batch manufacturing, stability studies, regulatory document preparation, and support for response during market authorization reviewing period. Collectively, we can offer professional support at every stage, from product development to commercial launch.
With solid R&D and analytical capabilities, optimized project management, extensive experience in international market authorization applications, as well as top quality manufacturing services, UBI Pharma is your reliable partner for obtaining international drug licenses for your products.